Autologous bone marrow derived stem cell therapy in traumatic spinal cord injury: A case report and review of literature

Abstract

Spinal cord injury (SCI) is a devastating condition. It not only creates enormous physical and emotional cost to the victims but also causes a financial burden to the society at large. The treatment of SCI focuses on preventing further injury and enabling people to return to an active and productive life within limits of their disability. Recently there is great excitement about the possibility of generating neural progenitor cells from sources such as mesenchymal cells derived from skin, bone-marrow, or adipose tissue. Stem cell therapy in traumatic spinal cord injury is an on going area of research in many centres in India and abroad. We describe a case of traumatic spinal cord injury with complete paraplegia in an adult where we had infused autologous bone marrow derived stem cell to damaged cord during fixation procedure and review the literature.

Keywords

Traumatic - Spinal cord injury - Autologous bone marrow - Stem cell therapy

• References

• 1 Barnabe-Heider F., Frisen J.. Stem cells for spinal cord repair. Cell Stem Cell 2008; 03: 16-24
• 2 Parr A.M., Tator C.H., Keating A.. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007; 40: 609-619
• 3 Alexanian A.R., Maiman D.J., Kurpad S.N., Gennarelli T.A.. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev 2008; 17: 1123-1130
• 4 Callera F., do Nascimento R.X.. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006; 34: 130-131
• 5 Deng Y.B., Liu X.G., Liu Z.G., Liu X.L., Liu Y., Zhou G.Q.. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy 2006; 08: 210-214
• 6 Rolls A., Shechter R., Schwartz M.. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 2009; 10: 235-241
• 7 Moviglia G.A., Varela G., Gaeta C.A., Brizuela J.A., Bastos F., Saslavsky J.. Autoreactive T cells induce in vitro BM mesenchymal stem cell transdifferentiation to neural stem cells. Cytotherapy 2006; 08: 196-201
• 8 Samijn J.P., te Boekhorst P.A., Mondria T.. et al Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatr 2006; 77: 46-50
• 9 Cristante A.F., Barros-Filho T.E., Tatsui N.. et al Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord 2009; 31
• 10 Deda H., Inci M.C., Kurekci A.E.. et al Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009; 11: 18-25
• 11 Chernykh E.R., Stupak V.V., Muradov G.M.. et al Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 2007; 143: 543-547
• 12 Moviglia G.A., Varela G., Brizuela J.A.. et al Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord 2009; 47: 499-503
• 13 Song S., Song S., Zhang H., Cuevas J., Sanchez-Ramos J.. Comparison of neuron like cells derived from bone marrow stem cells to those differentiated from adult brain neural stem cells. Stem Cells Dev 2007; 16: 747-756
• 14 Kumar Arachimani Anand, Kumar Sankaran Raj, Narayanan Raghavachary, Arul Kanagarajan, Baskaran Mayakesavan. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009; 04: 241-248